Key result
Both pre- and post-MI treatments with AdTNFR1 were deleterious in a mouse MI model, promoting ventricular rupture or exacerbating ventricular dysfunction and remodeling.
Why the study?
Does soluble TNF receptor treatment prevent adverse outcomes in a mouse model of myocardial infarction?
Does soluble TNF receptor treatment prevent adverse outcomes in a mouse model of myocardial infarction?
Answers are grounded in this paper and cite their sources.
Neutralization of TNF-alpha via soluble TNF receptors is deleterious in a mouse MI model, suggesting TNF-alpha plays a protective role post-MI, which may explain the failure of anti-TNF therapies in clinical trials.
OBJECTIVE: Tumor necrosis factor (TNF)-alpha induced in damaged myocardium has been considered to be cardiotoxic. However, the negative results of RENEWAL and ATTACH prompt us to reconsider the role of TNF-alpha in cardiovascular diseases. The present study aimed to evaluate the effects of soluble TNF receptor treatment on myocardial infarction (MI). METHODS: An adenovirus encoding a 55-kDa TNF receptor-IgG fusion protein (AdTNFR1) was used to neutralize TNF-alpha, and an adenovirus encoding LacZ (AdLacZ) served as control. In the pre-MI treatment protocol, mice were given an intravenous injection of AdTNFR1 or AdLacZ 1 week before left coronary artery ligation to induce MI. In the post-MI treatment protocol, mice were treated with AdTNFR1 or AdLacZ 1 week after left coronary ligation. RESULTS: Treatment with AdTNFR1 neutralized bioactivity of TNF-alpha that was activated after MI and prevented apoptosis of infiltrating cells in infarct myocardium. However, pre-MI treatment with AdTNFR1 promoted ventricular rupture by reducing fibrosis with further activation of matrix metalloproteinase (MMP)-9. Post-MI treatment with AdTNFR1 exacerbated ventricular dysfunction and remodeling, with enhanced fibrosis of non-infarct myocardium with further MMP-2 activation. CONCLUSIONS: Both pre- and post-MI treatments with AdTNFR1 were deleterious in a mouse MI model. Thus, TNF-alpha may play not only toxic but also protective roles in MI.
No takes yet. Share an insight, caveat, or question.
Monden et al. (2006) studied Myocardial infarction. AdTNFR1 (adenovirus encoding a 55-kDa TNF receptor-IgG fusion protein) vs. AdLacZ (adenovirus encoding LacZ) was evaluated on Ventricular rupture, remodeling, and dysfunction. Both pre- and post-MI treatments with AdTNFR1 were deleterious in a mouse MI model, promoting ventricular rupture or exacerbating ventricular dysfunction and remodeling.
Synapse has enriched 10 related papers. Consider them for comparative context: